ArticleWorld journal of virology2026
Emerging evidence of sand fly fever virus transmission in Sri Lanka.
Article in World journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSand fly fever virus (SFFV) infection is an acute self-limiting febrile illness caused by phleboviruses and transmitted by sand flies of the
aimTo detect other possible infection including SSFV in patients with clinically suspected dengue fever with negative serology results for NS1 antigen.
methodsIn this study, a total of 757 serum samples were collected from patients clinically suspected of dengue fever and admitted to three major hospitals in Sri Lanka between January and August 2023. Patients were from the Colombo and Kandy District, and demographic information was obtained from laboratory request forms, although detailed individual-level demographic data were limited due to anonymization in this laboratory-based study. All samples were initially screened for dengue NS1 antigen negativity and further tested for a panel of pathogens including SFFV immunoglobulin (Ig) M, hantavirus IgM, chikungunya IgM, and leptospira IgM antibodies, as well as molecular detection of hantavirus, flavivirus, and alphavirus RNA.
resultsFrom tested samples, two samples were serologically positive for SFFV-specific IgM using a commercial immunoblot assay, while all other tests for dengue, chikungunya, leptospira, hantavirus, and related RNA viruses were negative. These two SFFV-positive cases were from Kandy District and included one child (6-8 years) and one adult (40-50 years), both presenting with uncomplicated dengue-like illness.
conclusionThis study provides the first evidence of SFFV infection in Sri Lanka. Given the high endemicity of dengue in the country, SFFV infections may be clinically misdiagnosed as dengue and therefore remain under-recognized. Further studies involving febrile patients and sand fly vector surveillance are required to determine the true burden and epidemiological significance of SFFV in Sri Lanka.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.